12 drug makers likely to file complaint against data fabrication

Published: 2006-07-18 06:57:00

Updated: 2006-07-18 06:57:00

A total number of 12 local pharmaceutical firms are threatening to lodge their complaints against the cancellation of their generic products, following the recent announcement of the Korea Food and Drug Administration that a number of domestic bioresearch centers and pharmaceutical schools have b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK